| Comment | Response |
|---|---|
| One commentator expressed concern that this section does not address developing regulatory provisions (for statutory reporting) regarding estimation of incurred claims for certain long-term products. | The reviewers note, as described in section 1.2, that this standard does not address interpretation of statutory or generally accepted accounting principles, and believes that the description of the tabular method is broad enough to include required adjustments, such as required use of company experience. |
| Comment | Response |
|---|---|
| One commentator suggested adding “benefit periods or lifetime maximums” to the list of factors. | The reviewers added language to clarify that this list is not intended to be exhaustive. |
| One commentator noted that “long-term disability” is mentioned, but not “long-term care,” although they are similar. | The reviewers agree and removed this language. |
| Response | The reviewers agree and made the change. |
| One commentator suggested using “reported/unreported” instead of “known/unknown.” | The reviewers agree and made the change. |
| Comment | Response |
|---|---|
| One commentator questioned the inclusion of the specific example of pharmacy claims. | The reviewers believe it is common practice to rely on pharmacy claims because, for example, they are believed to complete more quickly than other claims, and they are an indicator of morbidity. The reviewers made no change. |
